4.6 Article

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020

Antonin Bal et al.

Summary: The study reported the strategy leading to the first detection of the variant of concern 202012/01 (VOC) in France, by screening for mutations such as Delta H69/Delta V70 associated with VOC and identifying co-occurring mutations like S:N501Y.

EUROSURVEILLANCE (2021)

Article Infectious Diseases

Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays

Abhinav Jain et al.

Summary: The SARS-CoV-2 epidemic originating from Wuhan rapidly evolved into a global pandemic, highlighting the importance of molecular detection using RT-PCR, although mutations in the viral genome could impact the accuracy of detection assays. The analysis of global SARS-CoV-2 genomes identified multiple genetic variants that could affect the effectiveness of diagnostic primers and probes.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Emergence of a new SARS-CoV-2 variant in the UK

Julian W. Tang et al.

JOURNAL OF INFECTION (2021)

Letter Medicine, General & Internal

An action plan for pan-European defence against new SARS-CoV-2 variants

Viola Priesemann et al.

LANCET (2021)

Article Multidisciplinary Sciences

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Lewis F. Buss et al.

Summary: Research indicates that the attack rate of COVID-19 in Manaus, the capital of Amazonas state in northern Brazil, reached 66% in June 2020, rising to 76% by October, higher than the estimated attack rate of 29% in Sao Paulo, southeastern Brazil, during the same period.

SCIENCE (2021)

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Letter Public, Environmental & Occupational Health

Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based CONSTANCES cohort

Fabrice Carrat et al.

Summary: Through testing serum samples from a French general population-based cohort, researchers found participants with positive anti-SARS-CoV-2 IgG test results, some of whom showed early symptoms or potential exposure to SARS-CoV-2 between November 2019 and January 2020.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Infectious Diseases

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

Alexandre Gaymard et al.

Summary: The emergence of the SARS-CoV-2 variant 201/501Y.V1 in France is concerning due to its increased transmissibility. Recent data shows that this variant is 52-69% more transmissible compared to previously circulating lineages, with a prevalence of 6.9% in the Paris region.

EUROSURVEILLANCE (2021)

Article Infectious Diseases

Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021

Vitor Borges et al.

Summary: The study found that the B.1.1.7 lineage of SARS-CoV-2 is highly disseminated in Portugal, with an estimated 89% increase per week. RT-PCR spike gene target late detection (SGTL) can be a useful tool to track the spread, showing higher viral loads in SGTL/SGTF samples without significant age distribution shifts.

EUROSURVEILLANCE (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 Viral Variants-Tackling a Moving Target

John R. Mascola et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Letter Medicine, General & Internal

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Wenjuan Zhang et al.

Summary: The research focused on sequencing and phylogenetic analyses of SARS-CoV-2 isolates from symptomatic patients at Cedar-Sinai Medical Center in November-December 2020, providing insights into a surge in cases and hospitalizations during that period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet et al.

LANCET (2021)

Editorial Material Medicine, General & Internal

Future scenarios for the COVID-19 pandemic

David Skegg et al.

LANCET (2021)

Editorial Material Medicine, General & Internal

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Ester C. Sabino et al.

LANCET (2021)

Article Multidisciplinary Sciences

Detection of a SARS-CoV-2 variant of concern in South Africa

Houriiyah Tegally et al.

Summary: The article describes a newly emerged lineage of SARS-CoV-2, 501Y.V2, characterized by eight mutations in the spike protein, which may result in increased transmissibility or immune escape. This lineage originated in South Africa and quickly became dominant in Eastern Cape, Western Cape, and KwaZuluNatal provinces within weeks.

NATURE (2021)

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Review Immunology

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19

Carmen Elena Gomez et al.

Summary: SARS-CoV-2 variants with higher transmissibility and mutations in the spike protein have direct implications on infection rates and resistance to antibodies. These variants have significant impacts on medical countermeasures and human health.

VACCINES (2021)

Review Immunology

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies

Lianlian Bian et al.

Summary: The global spread of the SARS-CoV-2 pandemic has led to the emergence of several variants, posing challenges to vaccine efficacy. However, some vaccines have shown advantages in providing protection against certain variants. Response strategies have been proposed to address the challenges posed by emerging variants, including accelerating the rollout of current vaccines, enhancing vaccine immunogenicity, and developing next-generation vaccines targeting the variants.

EXPERT REVIEW OF VACCINES (2021)

Article Infectious Diseases

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Dan Frampton et al.

Summary: This study describes the emergence of the B.1.1.7 variant of concern, its virological characteristics, and clinical severity in patients. Increased viral load was found in B.1.1.7 infection, but no association with severe disease was identified in the hospitalized cohort.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Nicholas G. Davies et al.

Summary: Studies have shown that the SARS-CoV-2 B.1.1.7 lineage is more transmissible and may cause more severe illness compared to pre-existing variants.

NATURE (2021)

Article Biochemistry & Molecular Biology

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Delphine Planas et al.

Summary: The ability of convalescent sera from individuals with coronavirus disease 2019 and those vaccinated with BNT162b2 to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351 decreases, but increases after two vaccine doses. The study found that the B.1.1.7 and B.1.351 variants may have acquired partial resistance to neutralizing antibodies generated by natural infection or vaccination, particularly in individuals with low antibody levels. This suggests that the B.1.351 variant may pose a greater risk of infection in immunized individuals.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman et al.

Summary: Despite evidence of vaccine efficacy, two fully vaccinated individuals developed mild symptoms of Covid-19 and were infected with variants of SARS-CoV-2. Sequencing of the virus isolates revealed novel mutations, highlighting the potential risk of illness post-vaccination and subsequent infection with variant virus. Efforts to prevent, diagnose, and characterize variants in vaccinated individuals are crucial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021

Corinne N. Thompson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Oncology

A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracy

Paul Hofman et al.

Summary: The study concluded that the Idylla (TM) SARS-CoV-2 Test is highly sensitive, specific, rapid, and user-friendly in distinguishing between symptomatic SARS-CoV-2 positive and negative patients in selected settings.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Letter Immunology

Novel SARS-CoV-2 Variant Derived from Clade 19B, France

Slim Fourati et al.

Summary: A novel SARS-CoV-2 variant, named HMN.19B variant or Henri Mondor variant, with 18 amino acid substitutions including 7-8 in the spike protein and 2 deletions, is actively circulating in different regions of France.

EMERGING INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Evolution patterns of SARS-CoV-2: Snapshot on its genome variants

Marta Giovanetti et al.

Summary: The novel coronavirus causing COVID-19 is a major threat with high morbidity and mortality rates, making it difficult to determine infectivity due to continuous evolution. It is urgent to study the virus deeply to understand its pathogenicity and virulence and develop effective therapeutic strategies. This article summarizes current knowledge on the virus's evolutionary and structural features to clarify its mutational pattern and potential role in the ongoing pandemic.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Virology

Genetic variants and source of introduction of SARS-CoV-2 in South America

Julio A. Poterico et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Biochemistry & Molecular Biology

On the evolutionary epidemiology of SARS-CoV-2

Troy Day et al.

CURRENT BIOLOGY (2020)

Article Public, Environmental & Occupational Health

Variant analysis of SARS-CoV-2 genomes

Takahiko Koyama et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)

Article Microbiology

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Andrew Rambaut et al.

NATURE MICROBIOLOGY (2020)

Article Genetics & Heredity

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Yujiro Toyoshima et al.

JOURNAL OF HUMAN GENETICS (2020)